SEC 13F Intelligence

Alerce Investment Management, L.P. / AKBA

Alerce Investment Management, L.P.’s Akebia Threapeutics Inc Position

Does Alerce Investment Management, L.P. own Akebia Threapeutics Inc (AKBA)? Yes — 5.75M shares worth $11M (+19.23% of its 13F portfolio) as of Q4 2024.

Position Value
$11M
Q4 2024
Shares
5.75M
% of Portfolio
+19.23%
Quarters Held
17
currently held

Position History AKBA

Reported value by quarter
Q4 ’20: $13MQ4 ’20Q1 ’21: $16MQ2 ’21: $18MQ3 ’21: $13MQ3 ’21Q4 ’21: $11MQ1 ’22: $3MQ2 ’22: $2MQ2 ’22Q3 ’22: $1MQ4 ’22: $9MQ1 ’23: $9MQ1 ’23Q2 ’23: $15MQ3 ’23: $18MQ4 ’23: $20MQ4 ’23Q1 ’24: $24MQ2 ’24: $6MQ3 ’24: $8MQ3 ’24Q4 ’24: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20245.75M$11M+19.23%
Q3 20245.75M$8M+12.17%
Q2 20245.75M$6M+11.49%
Q1 202413.21M$24M+25.42%
Q4 202316.21M$20M+26.74%
Q3 202316.21M$18M+31.57%
Q2 202316.21M$15M+19.29%
Q1 202316.21M$9M+12.00%
Q4 202215.09M$9M+10.02%
Q3 20224.65M$1M+1.42%
Q2 20224.65M$2M+3.05%
Q1 20224.65M$3M+5.66%
Q4 20214.65M$11M+10.69%
Q3 20214.65M$13M+9.17%
Q2 20214.65M$18M+9.57%
Q1 20214.65M$16M+6.97%
Q4 20204.65M$13M+5.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Alerce Investment Management, L.P.’s full portfolio or all institutional holders of AKBA.